|

CYTALUX™ (pafolacianine) Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Early 1: 1Phase 4: 1

Top Sponsors

  • Cedars-Sinai Medical Center1
  • Abramson Cancer Center at Penn Medicine1

Indications

  • Cancer2
  • Planned Diagnostic Laparoscopies1
  • CYTALUX (Pafolacianine) Injection1
  • Near Infrared Fluorescence Imaging1
  • Gastrointestinal Cancer1

Los Angeles, California1 trial

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

Cedars-Sinai Medical Center

Phase 4

Philadelphia, Pennsylvania1 trial

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

Abramson Cancer Center at Penn Medicine

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.